Connection
Michael Szarek to Clinical Trials as Topic
This is a "connection" page, showing publications Michael Szarek has written about Clinical Trials as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.091 |
|
|
|
-
Frydman H, Szarek M. Nonparametric estimation in a Markov "illness-death" process from interval censored observations with missing intermediate transition status. Biometrics. 2009 Mar; 65(1):143-51.
Score: 0.047
-
Newman CB, Palmer G, Silbershatz H, Szarek M. Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients. Am J Cardiol. 2003 Sep 15; 92(6):670-6.
Score: 0.034
-
Newman C, Tsai J, Szarek M, Luo D, Gibson E. Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients. Am J Cardiol. 2006 Jan 01; 97(1):61-7.
Score: 0.010